CM vs IBN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is concerning, highlighted by a weak Piotroski F-Score of 2/9, indicating significant deterioration in fundamental financial strength. While the company exhibits explosive growth (Earnings +46.6% YoY) and a strong track record of earnings beats, these are countered by a severely bearish technical trend (10/100) and a current price that has already exceeded analyst target prices. The stock trades at a premium to its Graham Number ($89.37) but remains well below its growth-based intrinsic value ($207.09), suggesting a conflict between short-term health risks and long-term growth potential.
The deterministic health profile is concerning, highlighted by a weak Piotroski F-Score of 2/9, indicating deteriorating operational trends. However, the valuation remains attractive with a PEG ratio of 0.52 and a current price ($27.54) sitting below the growth-based intrinsic value of $31.16. While revenue growth is explosive at 66.90%, the technical trend is currently bearish (0/100) and the 1-year price performance is negative. The stock presents a conflict between strong growth/valuation metrics and poor short-term financial health and price momentum.
Compare Another Pair
Related Comparisons
CM vs IBN: Head-to-Head Comparison
This page compares Canadian Imperial Bank of Commerce (CM) and ICICI Bank Limited (IBN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.